Table 3.
Comparison between groups across the postoperative variables.
| Category | Variable | Control | Oncoplastic surgery | Total | p |
|---|---|---|---|---|---|
| Surgical weight | g | 208.62 ± DP 139.97 | 307.40 ± DP 221.04 | 241.55 ± DP 176.17 | 0.04 |
| Surgical margin | mm | 11.85 ± DP 8.36 | 16.44 ± DP 8.64 | 13.23 ± DP 8.64 | 0.06 |
| Follow up | Months | 64.88 ± DP 24.53 | 60.01 ± DP 18.19 | 67.13 ± DP 22.61 | 0.33 |
| Bilateral surgery | Absent | 47 (90.4%) | 21 (80.8%) | 68 (87.2%) | 0.17 |
| Benign | 3 (5.8%) | 5 (19.2%) | 8 (10.3%) | ||
| Tumor | 2 (3.8%) | 0 | 2 (2.6%) | ||
| MDA [16] response | Stable | 2 (3.8%) | 1 (3.8%) | 3 (3.8%) | 1.00 |
| Mass | 27 (51.9%) | 14 (53.8%) | 41 (52.6%) | ||
| Multifocal | 8 (15.4%) | 4 (15.4%) | 12 (15.4%) | ||
| Without disease | 15 (28.8%) | 7 (26.9%) | 22 (28.2%) | ||
| PCR | Present | 16 (30.8%) | 5 (19.2%) | 21 (26.9%) | 0.42 |
| Absent | 36 (69.2%) | 21 (80.8%) | 57 (73.1%) | ||
| Local recurrence | Absent | 46 (88.5%) | 24 (92.3%) | 70 (89.7%) | 0.71 |
| Present | 6 (11.5%) | 2 (7.7%) | 8 (10.3%) | ||
| Locoregional recurrence | Absent | 45 (86.5%) | 23 (88.5%) | 68 (87.2%) | 1.00 |
| Present | 7 (13.5%) | 3 (11.5%) | 10 (12.8%) | ||
| Final status | CD | 11 (21.2%) | 4 (15.4%) | 15 (19.2%) | 0.55 |
| ADD | 3 (5.8%) | 2 (7.7%) | 5 (6.4%) | ||
| Recurrence | 3 (5.8%) | 0 | 3 (3.8%) | ||
| Recurrence free | 35 (67.3%) | 20 (76.9%) | 55 (70.5%) |
CD = Cancer death; ADD = associated diseases death; PCR = pathologic complete response; MDA = M.D.Anderson.